Atrovent Générique en inhalation est utilisé pour prévenir les bronchospasmes ou le rétrécissement des voies respiratoires dans les poumons chez les patients atteints de bronchite, d'emphysème ou de la maladie pulmonaire obstructive chronique (MPOC).
Twelve Men Charged in Connection with Multi-Million-Dollar Pharmaceutical Thefts - Federal Bureau of Investigation (press release)
Twelve Men Charged in Connection with Multi-Million-Dollar Pharmaceutical TheftsFederal Bureau of Investigation (press release)Sandoz estimates the WAC of the stolen medicine—including DuoNeb, a prescription combination medication containing Albuterol Sulfate and Ipratropium Bromide and indicated for patients with Chronic Obstructive Pulmonary Disease—to be $1.
Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for ... - MarketWatch (press release)
Elevation Pharmaceuticals Announces Positive Phase 2b Results for EP-101 for .
Feds bust $80M stolen drug ring - Cliffviewpilot.com
Feds bust $80M stolen drug ringCliffviewpilot.
Phase 2 Results for EP-101 Positive - Drug Discovery & Development
Phase 2 Results for EP-101 PositiveDrug Discovery & DevelopmentEP-101 was well-tolerated with a safety and side effect profile comparable to placebo and two active comparators (once daily tiotropium bromide [Spiriva] via Handihaler and three times daily ipratropium bromide via a conventional jet nebulizer).